PT - JOURNAL ARTICLE AU - Teixeira, Paula C AU - Dorneles, Gilson P AU - Filho, Paulo C Santana AU - Silva, Igor M da AU - Schipper, Lucas L AU - Postiga, Isabelle AL AU - Moreira Neves, Carla Andretta AU - Rodrigues Júnior, Luiz Carlos AU - Peres, Alessandra AU - de Souto, Janeusa Trindade AU - da Fonseca, Simone Gonçalves AU - Eller, Sarah AU - Oliveira, Tiago F AU - Rotta, Liane N. AU - Thompson, Claudia AU - Romão, Pedro R T TI - Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients AID - 10.1101/2021.06.24.21259468 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.24.21259468 4099 - http://medrxiv.org/content/early/2021/06/26/2021.06.24.21259468.short 4100 - http://medrxiv.org/content/early/2021/06/26/2021.06.24.21259468.full AB - This study aimed to evaluate the link between microbial translocation markers and systemic inflammation at the earliest time-point after hospitalization and at the last 72 h of hospitalization in survivors and non-survivors COVID-19 patients. Sixty-six SARS-CoV-2 RT-PCR+ infected patients and nine non-COVID-19 pneumonia controls were admitted in this study. Blood samples were collected at hospital admission (T1) (Controls and COVID-19+ patients) and 0-72 h before hospital discharge (T2, alive or dead) to analyze systemic cytokines and chemokines, LPS concentrations and soluble CD14 (sCD14) levels. THP-1 human monocytic cell line was incubated with plasma from survivors and non-survivors COVID-19 patients and their phenotype, activation status, TLR4, and chemokine receptors were analyzed by flow cytometry. COVID-19 patients presented higher IL-6, IFN-γ, TNF-α, TGF-β1, CCL2/MCP-1, CCL4/MIP-1β, and CCL5/RANTES levels than controls. Moreover, LPS and sCD14 were higher at hospital admission in SARS-CoV-2-infected patients. Non-survivors COVID-19 patients had increased LPS levels concomitant with higher IL-6, TNF-α, CCL2/MCP-1, and CCL5/RANTES levels at T2. Increased expression of CD16 and CCR5 were identified in THP-1 cells incubated with the plasma of survivor patients obtained at T2. The incubation of THP-1 with T2 plasma of non-survivors COVID-19 leads to higher TLR4, CCR2, CCR5, CCR7, and CD69 expression. In conclusion, increased microbial translocation during hospitalization coexist with the inflammatory condition of SARS-CoV-2 infection and could lead to higher monocyte activation in non-survivors COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded, in part, with support from the FAPERGS, CAPES Finance Code 001, CNPq and Federal University of Health Sciences of Porto Alegre. GPD is recipient of a PNPD/CAPES fellowship. PRTR is Research Career Awardees of the CNPq.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the UFCSPA Ethics Committee (CAAE: 38886220.0.0000). Informed consent was obtained from those legally responsible for the patients after the procedures had been explained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available when requested.